Japan· JP-3961006X1019
トルブタミド
A tolbutamide product containing トルブタミド, registered in Japan, on the national reimbursement list. The same ATC class is registered in 4 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Tolbutamide is registered in 4 of 19 countries.
Countries holding a registration under ATC A10BB03 (tolbutamide), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 1 of them publish a price we can compare per daily dose
Tolbutamide · ATC A10BB03
4 / 19 countries
- Finlandprice
- Japan
- Netherlands
- United Kingdom
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- トルブタミド
- Manufacturer
- —
- Country
- Japan (JP)
- ATC code
- A10BB03
- ATC class
- Tolbutamide
- Defined daily dose
- 1.5 g, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
556 interactions on record for tolbutamide.
Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tolbutamide · interactions on record
556 records
- 20 severe
- 463 moderate
- 55 minor
- 18 info
Most severe, free to view
- MiconazoleA07AC01severe
- Magnesium carbonateA02AA01moderate
- Magnesium oxideA02AA02moderate
- Magnesium hydroxideA02AA04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A10BB03
Tolbutamide, as other registers publish it.
- FinlandRastinonHOECHST-FENNICA
- FinlandRastinonHOECHST-FENNICA
- United KingdomTolbutamide 1g/5ml oral suspensionSpecial Order
- United KingdomTolbutamide 250mg/5ml oral suspensionSpecial Order
- United KingdomTolbutamide 500mg tabletsSovereign Medical Ltd
- United KingdomTolbutamide 500mg tabletsWaymade Healthcare Plc
- United KingdomTolbutamide 500mg tabletsMedihealth (Northern) Ltd
- United KingdomTolbutamide 500mg tabletsA A H Pharmaceuticals Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cd6843db-c2e8-42de-abb0-591062989d38 GET /v1/drugs/cd6843db-c2e8-42de-abb0-591062989d38?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１ｇ",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "3961006X1019",
"category": "内用薬",
"price_yen": null,
"generic_name": "トルブタミド",
"product_name_jp": null,
"therapeutic_class": "3961",
"transitional_expiry": null
}See everything about tolbutamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.